Work-up and diagnosis pediatric non-Hodgkin's lymphomas

Pediatric and Developmental Pathology

Volumn 3, Issue 4, 2000, Pages 374-390

  Perkins, Sherrie L ^a  

^a ARUP LABORATORIES   (United States)

Author keywords

Anaplastic large cell lymphoma; Burkitt's lymphoma; Large cell lymphoma; Lymphoblastic lymphoma; Pediatric non Hodgkin's lymphoma

Indexed keywords

ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CHILDHOOD CANCER; HISTOPATHOLOGY; HUMAN; LARGE CELL LYMPHOMA; LYMPHOBLASTOMA; LYMPHOCYTOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

ADOLESCENT; BURKITT LYMPHOMA; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; HUMANS; LYMPHOMA, LARGE-CELL; LYMPHOMA, LYMPHOBLASTIC; LYMPHOMA, NON-HODGKIN; SPECIMEN HANDLING;

EID: 0033943037     PISSN: 10935266     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100249910052     Document Type: Article

References (96)

1. Perkins SL, Segal GH, Kjeldsberg CR. Work-up of lymphadenopathy in children. Semin Diagn Pathol 1995;12:284-287.
2. Grossman M, Shiramizu B. Evaluation of lymphadenopathy in children. Curr Opin Pediatr 1994;6:68-76.
3. Cotelingham J, Witesby F, et al. Malignant lymphoma in patients with the Wiscott-Aldrich syndrome. Cancer Invest 1985;3:515-521.
4. Filipovich AH, Mathur A, Kamat D, et al. Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res 1992;52(suppl):5465s-5467s.
5. Levine A. Acquired immunodeficiency syndrome-related lymphoma. Blood 1992;80:8-20.
6. Wilson J, Jenkin R, Anderson J, et al. Studies on the pathology of non-Hodgkin's lymphoma of childhood. I. The role of routine histopathology as a prognostic factor. A report from the Children's Cancer Study Group. Cancer 1984;53:1695-1704.
7. Kjeldsberg C, Wilson J, Berard C. Non-Hodgkin's lymphoma in children. Hum Pathol 1983;14:612-627.
8. Murphy S, Fairclough D, Hutchinson R, et al. Non-Hodgkin's lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution. J Clin Oncol 1989;7:186-193.
9. Reiter A, Schrappe M, Parawesch R, et al. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stages - a report of the Berlin-Frankfurt-Munster Group. J Clin Oncol 1995;13:359-372.
10. Patte C, Philip T, Rodary C, et al. High survival rate in advanced B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol 1991;9:123-132.
11. Reiter A, Schrappe M, Ludwig WD, et al. Favorable outcome children and adolescents with T-cell lymphoblastic lymphoma (T-LBL) with an intensive ALL-type therapy without local radiotherapy. Ann Oncol 1999;10: 1079-1085.
12. Brugieres L, LeDeley MC, Pacquement H, et al. CD30+ anaplastic large cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology. Blood 1998;92:3591-3598.
13. Silverman J, Joshi V. FNA biopsy of small round cell tumors of childhood: cytomorphologic features and the role of ancillary studies. Diagn Cytopathol 1994;10:245-255.
14. Howell L, Russell L, Howard P, et al. The cytology of pediatric masses: a differential diagnosis approach. Diagn Cytopathol 1992;8:107-115.
15. Hallman J, Geisinger K. Cytology of fluids from pleural, peritoneal and pericardial cavities in children. A comprehensive review. Acta Cytol 1994;38:209-217.
16. Tubbs R, Sheibani K. Immunohistology of lymphoproliferative disorders. Semin Diagn Pathol 1984;1:272-284.
17. Melphan B. Effects of fixatives on the immunoreactivity of paraffin sections. Histochem J 1982;14:731-737.
18. Perkins S, Kjeldsberg C. Immunophenotyping of lymphomas and leukemias in paraffin-embedded tissues. Am J Clin Pathol 1993;99:362-372.
19. Weiss L, Chen Y-Y. Effects of different fixatives on detection of nucleic acids from paraffin-embedded tissues by in situ hybridization using oligonucleotide probes. J Histochem Cytochem 1991;39:1237-1242.
20. Greer C, Peterson S, Kiviat N, et al. PCR amplification from paraffin-embedded tissues. Effects of fixative and fixation time. Am J Clin Pathol 1991;95:117-124.
21. Lillie R, Fullmer H. Histopathologic Technic and Practical Histochemistry, 4th ed. New York: McGraw-Hill Book, 1976.
22. Koo C, Rappaport H, Sheibani K, et al. Imprint cytology of non-Hodgkin's lymphomas. Hum Pathol 1989;20:1-138.
23. Grody W, Gatti R, Naeim F. Diagnostic molecular pathology. Mod Pathol 1989;2:553-568.
24. Goldsby R, Carroll W. The molecular biology of pediatric lymphomas. J Pediatr Hematol Oncol 1998;20:282-296.
25. Armes J, Southey M, Eades S, et al. Molecular analysis in the diagnosis of pediatric lymphomas. Pediatr Pathol Lab Med 1996;16:435-449.
26. Murphy S. Classification, staging and end results of treatment of childhood non-Hodgkinn's lymphomas: dissimilarities from lymphomas in adults. Semin Oncol 1980;7: 332-338.
27. Perkins S, Segal G, Kjeldsberg C. Classification of non-Hodgkin's lymphomas in children. Semin Diagn Pathol 1995;12:303-313.
28. Sandlund JT, Downing JR, Christ WM. Non-Hodgkin's lymphoma in childhood. N Engl J Med 1996;334:1238-1248.
29. Rappaport H. Tumors of the Hematopoietic System. Atlas of Tumor Pathology, Vol. 8. Washington D.C.: U.S. Armed Forces Institute of Pathology, 1966;98.
30. Lukes R. The immunologic approach to the pathology of malignant lymphomas. Am J Clin Pathol 1979;72:657-669.
31. Stansfield A, Diebold J, Kapanci G, et al. Updated Kiel classification for lymphomas. Lancet 1988;1:292-293.
32. The Non-Hodgkin's Lymphoma Pathologic Classification Project. The National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: summary and description of Working Formulation for clinical usage. Cancer 1982;49:2112-2135.
33. Harris N, Jaffe E, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-1392.
34. Head D, Behm F. Acute lymphoblastic leukemia and the lymphoblastic lymphomas of childhood. Semin Diagn Pathol 1995;12:325-334.
35. Picozzi V, Coleman C. Lymphoblastic lymphoma. Semin Oncol 1990;17:96-103.
36. Weiss M, Bindl J, Picozzi V, et al. Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia. Blood 1986;67:474-478.
37. Sheibani K, Nathwani B, Winberg C, et al. Antigenically defined subgroups of lymphoblastic lymphoma: relationship to clinical presentation and biologic behavior. Cancer 1987;60:183-190.
38. Soslow R, Baergen R, Warnke R. B-lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically aggressive lymphomas with blastic morphology. Cancer 1999;85:2648-2654.
39. Bennett J, Catovsky D, Daniel M, et al. Proposals for the classification of acute leukemias. French-American-British (FAB) Cooperative Group. Br J Hematol 1976;33:451-458.
40. Nathwani B, Diamond L, Winberg C, et al. Lymphoblastic lymphoma: a clinicopathologic study of 95 patients. Cancer 1981;48:2347-2357.
41. Griffith R, Kelly D, Nathwani B, et al. A morphologic study of childhood lymphoma of lymphoblastic type. The Pediatric Oncology Group experience. Cancer 1987;59:1126-1131.
42. Cossman J, Chused T, Fisher R, et al. Diversity of immunological phenotypes of lymphoblastic lymphoma. Cancer Res 1983;43:4486-4490.
43. Chu PG, Chang KL, Arber DA, et al. Practical applications of immunohistochemistry in hematolymphoid neoplasms. Ann Diagn Pathol 1999;3:104-133.
44. Orazi A, Cattoretti G, John K, et al. Terminal deoxytidyl transferase staining of malignant lymphomas in paraffin sections. Mod Pathol 1994;5:582-585.
45. Almasri N, Iturraspe J, Benson N, et al. Flow cytometric analysis of terminal deoxytidyl transferase. Am J Clin Pathol 1991;95:376-380.
46. Soslow R, Bhargava V, Warnke R. MIC2, TdT, bcl-2, and CD34 expression in paraffin-embedded high grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities. Hum Pathol 1997;28:1158-1165.
47. Pilozzi E, Muller-Hermelink H, Falini B, et al. Gene rearrangements in T-cell lymphoblastic lymphoma. J Pathol 1999;188:267-270.
48. Rubin C, LeBeau M. Cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol 1991;13:202-216.
49. Raimondi S. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 1993;81: 2237-2244.
50. Pavlova Z, Parker J, Taylor C, et al. Small noncleaved follicular center cell lymphoma: Burkitt's and non-Burkitt's variants in the U.S. Cancer 1987;59:1892-1902.
51. Wilson J, Kjeldsberg C, Sposto R, et al. The pathology of non-Hodgkin's lymphoma of childhood: reproducibility and relevance of the histologic classification of "undifferentiated" lymphomas (Burkitt's versus non-Burkitts). Hum Pathol 1987;18:1008-1014.
52. Hutchison R, Murphy S, Fairclough D, et al. Diffuse small noncleaved cell lymphoma in children, Burkitt's versus non-Burkitt's types. Results from the Pediatric Oncology Group and St. Judes Children's Research Hospital. Cancer 1989;64:23-28.
53. Lones M, Auperin A, Raphael M, et al. Mature B-cell lymphoma/leukemia in children and adolescents: intergroup pathologist consensus with the Revised European-American Lymphoma classification. Ann Oncol 2000;11:47-51.
54. Burkitt D. A sarcoma involving the jaws in African children. Br J Surg 1958;46:218-223.
55. Purtilo D, Strobach R, Okano M, et al. Epstein-Barr virus-associated lymphoproliferative disorders. Lab Invest 1992; 67:5-23.
56. Miliaukas J, Berard C, Young R, et al. Undifferentiated non-Hodgkin's lymphoma (Burkitt's and non-Burkitt's types). The relevance of making this histologic distinction. Cancer 1982;50:2115-2121.
57. Chapman C, Zhou J, Gregory C, et al. VH and VL gene analysis in sporadic Burkitt's lymphoma shows somatic hypermutation, intraclonal heterogeneity, and a role for antigen selection. Blood 1996;88:3562-3568.
58. Kagan J. Molecular biology of chromosomal aberrations in leukemia/lymphoma. Hematol Pathol 1993;7:159-201.
59. Pagano J, Huang M, Levine P. Absence of Epstein-Barr viral DNA in American Burkitt's lymphoma. N Engl J Med 1973;289:1395-1401.
60. Spina D, Leoncini L, Megha T, et al. Cellular kinetic and phenotypic heterogeneity in and among Burkitt's and Burkitt-like lymphomas. J Pathol 1997;182:145-150.
61. Cigudosa J, Parsa N, Louie D, et al. Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas. Genes Chromosom Cancer 1999;25:123-133.
62. Wright D, McKeever P, Carter R. Childhood non-Hodgkin's lymphomas in the United Kingdom: findings from the UK Children's Cancer Study Group. J Clin Pathol 1997;50:128-134.
63. Effect of age on the characteristics and clinical behavior of non-Hodgkin's lymphoma patients. The Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 1997;8:973-978.
64. Nathwani B, Griffith R, Kelly DR, et al. A morphologic study of childhood lymphoma of the diffuse "histiocytic" type. The Pediatric Oncology Group experience. Cancer 1987;59:1138-1142.
65. Weiss R, Kjeldsberg C, Colby T, et al. Multilobated B cell lymphomas: a study of 7 cases. Hematol Oncol 1985;3:79-86.
66. Macon W, Williams M, Greer J, et al. T-cell rich B-cell lymphomas. A clinicopathologic study of 19 cases. Am J Surg Pathol 1992;16:351-363.
67. Lones M, Cairo M, Perkins S. T-cell rich large B-cell lymphoma in children and adolescents: a clinicopathologic report of six cases from the Children's Cancer Group Study CCG-5961. Cancer (In press).
68. Piira T, Perkins S, Anderson J, et al. Primary mediastinal large cell lymphoma in children: a report from the Children's Cancer Group. Pediatr Pathol Lab Med 1995;15:561-570.
69. Lamarre L, Jacobson J, Aisenberg A, et al. Primary large cell lymphoma of the mediastinum. Am J Surg Pathol 1989;13:730-737.
70. Addis B, Issacson P. Large cell lymphoma of the mediastinum: a B-cell tumor of probable thymic origin. Histopathology 1986;10:379-385.
71. Moller P, Moldenhauer G, Mornburg F, et al. Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B-cell differentiation. Blood 1987;69: 1087-1096.
72. Higgin JP, Warnke RA. CD30 expression is common in mediastinal large B-cell lymphoma. Am J Clin Pathol 1999; 112:241-247.
73. Chadburn A, Frizzera G. Mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma. Am J Clin Pathol 1999;112:155-158.
74. Agnarsson B, Kadin M. Peripheral T-cell lymphomas in children. Semin Diagn Pathol 1995;12:314-324.
75. Kadin M. Anaplastic large cell lymphoma and its morphologic variants. Cancer Surv 1997;30:77-86.
76. Kinney M, Kadin M. The pathologic and clinical spectrum of anaplastic large cell lymphoma and correlation with ALK gene dysregulation. Am J Clin Pathol 1999; 111:S57-S67.
77. Palleson G, Hamilton-Dutoit SJ. Ki-1 (CD30) antigen is regularly expressed by tumor cells of embryonal carcinoma. Am J Pathol 1988;133:446-451.
78. Schwarting R, Gerdes J, Durkop H, et al. BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 1989;74:1678-1673.
79. Segal GH, Kjeldsberg CR, Smith GS, et al. CD30 antigen expression on florid immunoblastic proliferations: a clinicopathologic study of 14 cases. Am J Clin Pathol 1994; 102:292-298.
80. Agnarrson B, Kadin M. Ki-1 positive large cell lymphoma. A morphologic and immunologic study of 19 cases. Am J Surg Pathol 1988;12:264-274.
81. Kadin M, Morris S. The t(2;5) in human lymphomas. Leuk Lymphoma 1998;29:249-256.
82. Ladanyi M. The NPM/ALK gene fusion in the pathogenesis of anaplastic large cell lymphoma. Cancer Surv 1997;30: 59-75.
83. Wlodarska I, deWolf-Peeters C, Falini B, et al. The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive anaplastic large cell lymphoma. Blood 1998; 92:2688-2695.
84. Lin BT, Musset M, Szekely AM, et al. Human T-cell lymphotropic virus-1-positive T-cell lymphoma/leukemia in a child. Report of a case and review of the literature. Arch Pathol Lab Med 1997;121:1282-1286.
85. Winberg C, Nathwani B, Bearman R, et al. Follicular (nodular) lymphoma during the first two decades of life: a clinicopathologic study of 12 patients. Cancer 1981;48: 2223-2235.
86. Frizzera G, Murphy S. Follicular (nodular) lymphoma in childhood: a rare clinical-pathological entity: report of eight cases from four cancer centers. Cancer 1979;44: 2218-2235.
87. Pinto A, Hutchinson R, Grant L, et al. Follicular lymphomas in pediatric patients. Mod Pathol 1990;3:308-313.
88. Finn LS, Viswantha DS, Belasco JB, et al. Primary follicular lymphoma of the testis in childhood. Cancer 1999;85: 1626-1635.
89. Berrebi D, Lescour B, Faye A, et al. MALT lymphoma of labial minor salivary gland in an immunocompetent child with a gastic Helicobacter pylori infection. J Pediatr 1998; 133:290-292.
90. Hung IJ, Kuo TT, Sun CF. Subcutaneous panniculitic T-cell lymphoma developing in a child with idiopathic myelofibrosis. J Pediatr Hematol Oncol 1999;21:38-41.
91. Weiss RL, Lazarus KH, Macon WR, et al. Natural killer-like T-cell lymphoma in the small intestine of a child without evidence of enteropathy. Am J Surg Pathol 1997; 21:964-969.
92. Corr P, Vaithilingum M, Thejpal R, et al. Parotid MALT lymphoma in HIV infected children. J Ultrasound Med 1997;16:615-617.
93. Joshi W, Gagnon GA, Chadwick EG, et al. The spectrum of mucosa-associated lymphoid tissue lesions in pediatric patients infected with HIV: a clinicopathologic study of six cases. Am J Clin Pathol 1997;107:592-600.
94. Link MP, Donaldson SS, Berard CW, et al. Results of treatment of childhood localized non-Hodgkin's lymphoma with combination chemotherapy without radiotherapy. N Engl J Med 1990;322:1169-1174.
95. Hvizdala E, Berard C, Callihan B, et al. Lymphoblastic lymphoma in children - a randomized trial comparing LSA2-A2 with the A-COP+ therapeutic regime: a Pediatric Oncology Group study. J Clin Oncol 1988;6:26-33.
96. Hvizdala EV, Berard C, Calihan T, et al. Nonlymphoblastic lymphoma in children histology and stage-related response to therapy: a Pediatric Oncology Group study. J Clin Oncol 1991;9:1189-1195.